Prairie Education & Research Cooperative Joins MedNet Solutions' iMedNet CRO Partner Program
Minnetonka, MN – MedNet Solutions, a global life sciences technology solutions company specializing in clinical study management systems, and Prairie Education & Research Cooperative (PERC), an organization specializing in cardiovascular and vascular trial management, core lab, and continuing medical education services, are pleased to announce that PERC has joined the iMedNetTM CRO Partner Program. PERC will leverage iMedNet EDC, MedNet’s innovative cloud‐based eClinical technology platform, to easily and cost‐effectively build and manage their customers’ clinical research studies.
“iMedNet EDC provides an ideal electronic data capture solution that is financially feasible for PERC’s budget sensitive companies while maintaining a high level of functionality and flexibility,” stated Cynthia Deitrick, Chief Operating Officer at PERC. “PERC looks forward to future business opportunities where iMedNet can be utilized as a seamless solution for clinical trial sponsors.”
“MedNet is honored to be working with PERC-a top quality, highly‐respected clinical services organization,” noted Brian Sweeney, Vice President of Business Development at MedNet Solutions. “We’re confident that iMedNet EDC will provide the effective and reliable technology infrastructure they need for years to come.”
Please contact MedNet Solutions for more information on iMedNet EDC or the iMedNet CRO Partner Program, and PERC for additional details on their cardiovascular and vascular clinical services.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- How the NIMBLE Study Supported Adherence With Quarterly Dosing of Cemdisiran
September 18th 2025
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025